Immunoglobulin A (IgA)- Structure, Subclasses and Functions

  • Antibodies, or ‘immunoglobulins’, are glycoproteins that bind antigens with high specificity and affinity.
  • In humans there are five chemically and physically distinct classes of antibodies (IgG, IgA, IgM, IgD, IgE).
  • Immunoglobulin A (IgA), is the major class of antibody present in the mucosal secretions of most mammals.
  • It is the key first line of defence against invasion by inhaled and ingested pathogens at mucosal surfaces.

Immunoglobulin A (IgA)- Structure, Subclasses and Functions

  • It is present in mucous, tears, saliva, sweat, colostrum and secretions from the genitourinary tract, gastrointestinal tract, prostate and respiratory epithelium. It is also found in small amounts in blood. 
  • It comprises approximately 15% of the total serum immunoglobulin and thus is the second most common human immunoglobulin in serum with serum concentration of 1 to 4 mg/mL.
  • In humans it is encoded by two genes within the immunoglobulin gene locus on chromosome 14. The 5′ IgA gene encodes IgA1 while 3′ IgA gene encodes IgA2.

IgA subclasses

  • Two IgA subtypes exist in humans, IgA1 und IgA2.
  • They differ in the molecular mass of the heavy chains and in their concentration in serum.
  • IgA1 also differs from IgA2 in being susceptible to cleavage in its hinge region by proteases secreted by a number of different bacteria.
  • In addition to that, IgA2 occurs in two allotypic forms, IgA2 (m1) and IgA2 (m2).

IgA1

– Predominant circulating IgA comprising approximately 85% of total IgA concentration in serum.

– IgA1 shows a good immune response to protein antigens and, to a lesser degree, polysaccharides and lipopolysaccharides.

IgA2

– IgA2, represents only up to 15% of total IgA in serum, but IgA2 percentages are higher in secretions.

– Plays a crucial role in the mucosa of the airways, eyes and the gastrointestinal tract to fight against polysaccharide and lipopolysaccaride antigens.

Structure of IgA

  • Immunoglobulin A (IgA) is present in the serum as a 170 kDa, four polypeptide (two L and two H) chain protein.
  • Its H-chain type is alpha (α).
  • IgA exists in serum in both monomeric and dimeric forms.
  • Although it exists primarily in monomeric form, followed by dimeric, trimeric and some tetrameric forms are also present.
  • IgA in blood occurs in monomeric form whereas those in body secretion occur in dimeric or multimeric forms.
  • In secretions, in addition to the κ or λ L-chains and the IgA heavy chain alpha, IgA also contains two other polypeptide chains – secretory component (SC) and J-chain (Joining chain).
  • Secretory chains help in transcytosis of exocrine IgA and stabilize IgA against proteolytic degradation.
  • The two four-chain units are held together by the J-chain through disulfide bridges.

Functions of IgA

  • It primarily protects mucous membranes as IgA can cross the epithelial layer and enter into body secretion providing local immunity.
  • Secretory IgA provides the primary defense mechanism against some local infections because of its abundance in mucosal secretions (e.g., saliva and tears).
  • It prevents the passage of foreign substances into the circulatory system.
  • In body secretion IgA neutralize viruses and prevent attachment on host surface.
  • IgA is resistant to digestion and although a poor activator, can activate the complement pathway when aggregated.
  • Secretory IgA can also inhibit inflammatory effects of other immunoglobulins.

References

  1. https://www.thermofisher.com/kr/en/home/life-science/antibodies/antibodies-learning-center/antibodies-resource-library/antibody-methods/immunoglobulin-iga-class.html
  2. https://www.bio-rad-antibodies.com/iga-immunoglobulin-a-antibody.html
  3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1782559/
  4. Lydyard, P.M., Whelan,A.,& Fanger,M.W. (2005).Immunology (2 ed.).London: BIOS Scientific Publishers.
  5. Playfair, J., & Chain, B. (2001). Immunology at a Glance. London: Blackwell Publishing

About Author

Photo of author

Sagar Aryal, PhD

Dr. Sagar Aryal is a microbiologist, researcher, and science communicator from Nepal. He is also co-founder and Research Head of the Department of Natural Products at the Kathmandu Research Institute for Biological Sciences (KRIBS), where he leads research on natural product discovery and microbial biodiversity. Dr. Aryal earned his Ph.D. in Microbiology from Tribhuvan University, Kathmandu, Nepal, in 2025, supported by a DAAD Research Grant and a University Grants Commission (UGC) Nepal Ph.D. Fellowship. His research interests include Actinomycetes, Myxobacteria, microbial taxonomy, and natural products, particularly the discovery of bioactive compounds with potential pharmaceutical applications. He isolated and identified Nocardia nepalensis, a novel bacterial species from Nepal, contributing to understanding microbial diversity in the region. Dr. Aryal has published more than 16 research articles in international journals and contributed three book chapters to established academic publications. He has presented scientific research findings and developed international research collaborations through visits to more than 18 countries across Asia, Europe, North America, and Oceania. From 2023 to 2025, he served as the American Society for Microbiology (ASM) Young Ambassador to Nepal. Since December 2025, he has served as an Editorial Board Member of Scientific Reports, a Nature Portfolio journal. In recognition of his scientific contributions, Dr. Aryal received the NAST Science and Technology Youth Award 2025 from the Nepal Academy of Science and Technology. He previously received the Frs. Locke and Stiller Research Award (LSRA) for the 2017-2018 cycle from St. Xavier's College, Kathmandu, and a Nepal Academy of Science and Technology (NAST) Research Grant for 2017-2018. Alongside his scientific career, Dr. Aryal has more than 15 years of experience in blogging, content writing, and search engine optimization (SEO).